A new study by Nigerian researchers that was published in the Journal of Pharmacy and Biological Science has claimed that SAAAB and HAABS – bitter leaf-based supplements – can cure hepatitis.
Clinical trials of the drugs demonstrated that the herbal preparations made predominantly from bitter leaf (Vernonia amygdalina) provide cure for chronic forms of Hepatitis B and C.
About 23 million Nigerians are infected with Hepatitis B, and 11 die every day, making Nigeria one of the countries with the highest hepatitis burden in the world.
Lead researcher, Ben Amodu of the Halamin Herbal Products in Abuja and lecturer at the Department of Histopathology and Cytology, Jos University Teaching Hospital (JUTH), said herbal medicine could succeed where orthodox one has failed in the treatment of both communicable and non-communicable diseases.
Amodu said, “This study has shown that there is a cure for the chronic form of hepatitis – HBV and HCV. The total clearance of HBV and HCV upon administration of SAAAB and HAABS for three weeks and one week respectively is a testimony to this fact.”
“Since prevention still remains the key to control, efforts must be made to strengthen strategies aimed at increasing awareness and encouraging people to take seriously the issue of vaccination.”
